| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.06 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.071 | 0.06 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.07 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | 0.083 | 0.07 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.064 | 0.07 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.057 | 0.07 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.07 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.087 | 0.07 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.07 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.09 | 0.07 |